Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Market Cap	$206.06M	P/E Ratio	N/A
52W High	$12.91	52W Low	$5.70
Div Yield	N/A	Payout Ratio	N/A
EPS Growth 3Y	-75.8%	52W Position	16.4%
Overall Score	50	Value Score	60
Quality Score	--	Technical Score	41

EPS Current Est	$-0.9	EPS Next Est	$-0.56
EPS Growth Est	N/A	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	INGN	$6.88	+4.40%	269.47K
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	INGN	$6.88	+4.4%	269.47K
3
4
5
6

INGN

INGN

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Inogen Inc Data in Excel

Get Inogen Inc Data in Excel